Embleema

Embleema helps research teams, registries, and patient organizations turn complex real-world data into regulatory-grade evidence. Our platform unifies clinical, molecular, and patient-reported data to accelerate insights, improve study quality, and reduce time to submission. The FDA uses Embleema’s platform for genomic regulatory evaluations and to help shape future CDISC standards for cell and gene therapies. We also power landmark initiatives such as the Lupus Landmark and Human Epilepsy Project, in collaboration with leading research networks including Johns Hopkins, NYU, UCSF, and Mayo Clinic. Whether you’re managing a disease registry, leading a post-market study, or advancing advocacy-driven research, Embleema connects every stakeholder—sites, sponsors, and patients—through one secure, compliant data infrastructure. Learn how Embleema’s regulatory-grade platform can strengthen your research from design to submission. Explore case studies and connect with our team by visiting us at